Benzinga | Dec 29, 2021 08:04AM EST

Universe Pharmaceuticals INC Announces Alliance With Jinggangshan University For Study On Chemical Constituents Of Certain Traditional Chinese Medicine

Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the "Agreement") with Jinggangshan University ("JGSU"), a public university located in Ji'an City of Jiangxi Province, for a study on the chemical constituents of Liparis Odorata, a traditional Chinese medicine, for the treatment of hyperlipidemia.



Under the Agreement, JGSU agrees to conduct the aforementioned studies and provide scientific research results to the Company, and report to the Company upon completion within 24 months from the date of the Agreement.

Mr. Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, commented, "We are excited to collaborate with JGSU on this research partnership since JGSU has an impressive track record of cutting-edge research in studies of Chinese medicines, and its expertise and resources will be invaluable to us. It is critical that pharmaceutical companies and academic institutions work together to develop Chinese medicine for diseases with significant unmet market and medical needs, and JGSU is one of the ideal partners to support us in this effort. Working with JGSU, we expect to be at the forefront of developing Chinese medicines with better efficacy and market recognition."